peptibase
Hormonal

Abaloparatide

Also known as: Tymlos, BA058

FDA Approved
Share:

Key Facts: Abaloparatide

Category
Hormonal
FDA Status
FDA Approved
Clinical Status
FDA Approved - Osteoporosis in postmenopausal women and men at high risk for fracture (male indication added Dec 2025)
Administration
Subcutaneous injection daily
Typical Dose
80 mcg daily
Frequency
Once daily
Duration
Maximum 2 years (same lifetime limit as teriparatide)
Also Known As
Tymlos, BA058

Mechanism of Action

Abaloparatide is an analog of PTH-related protein (PTHrP). It preferentially binds to the RG conformation of PTH1 receptor, favoring anabolic signaling over bone resorption. Results in bone building with less hypercalcemia.

Research Summary

ACTIVE trial showed superior reduction in vertebral and non-vertebral fractures vs placebo. Comparative data suggests similar or better efficacy than teriparatide with less hypercalcemia. Second anabolic osteoporosis drug approved.

Trial Progress:FDA Approved
Pre
I
II
III
IV
FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical Dosingⓘ

Community experience

Common Dose

80 mcg daily

Range

80 mcg daily

Frequency

Once daily

PTHrP analog for osteoporosis. Similar to teriparatide but different binding profile.

Research Dosingⓘ

Scientific studies

FDA-approved dosing

Doses from Studies

Duration

Maximum 2 years (same lifetime limit as teriparatide)

Administration

Subcutaneous injection daily

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • ●Hypercalciuria (11%)
  • ●Dizziness (10%)
  • ●Nausea (8%)
  • ●Palpitations (5%)
  • ●Injection site reactions
  • ●Orthostatic hypotension
  • ●Osteosarcoma risk in rats
  • ●FDA approved (Tymlos)

References

Research This Peptide Further

PubMedClinicalTrials.govFDA.gov

Frequently Asked Questions

What does Abaloparatide do?

A PTHrP analog that stimulates bone formation with potentially fewer side effects than teriparatide. Newer anabolic option for osteoporosis.

How does Abaloparatide work?

Abaloparatide is an analog of PTH-related protein (PTHrP). It preferentially binds to the RG conformation of PTH1 receptor, favoring anabolic signaling over bone resorption. Results in bone building with less hypercalcemia.

Is Abaloparatide FDA approved?

Yes, Abaloparatide is FDA approved. FDA Approved - Osteoporosis in postmenopausal women and men at high risk for fracture (male indication added Dec 2025)

What are the side effects of Abaloparatide?

Reported side effects include: Hypercalciuria (11%), Dizziness (10%), Nausea (8%), Palpitations (5%), Injection site reactions. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Abaloparatide?

Community-reported common dose: 80 mcg daily (Once daily). Range: 80 mcg daily. Administration: Subcutaneous injection daily. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Abaloparatide or used in similar applications.

Oxytocin

FDA

A naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.

Hormonal

Gonadorelin

FDA

A synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.

Hormonal

Leuprolide

FDA

A GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Hormonal

Desmopressin

FDA

A synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.

Hormonal

Octreotide

FDA

A synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.

Hormonal

Lanreotide

FDA

A long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.

Hormonal
How to Use AbaloparatideAbaloparatide AlternativesCompare with SimilarBrowse All Peptides

Want updates on Abaloparatide research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Back to all peptides